Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Wang

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Blood|September 12, 2007
Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcomaRichard F Little, Karen Aleman, Pallavi Kumar, et al.
Database : the Journal of Biological Databases and Curation|April 4, 2013
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptomeBenjamin Frederick Ganzfried, Markus Riester, Benjamin Haibe-Kains, et al.
Cancer Chemotherapy and Pharmacology|November 30, 2013
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancerTaofeek K Owonikoko, Joseph Aisner, Xin Victoria Wang, et al.
Plos One|October 27, 2015
A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex ImmunoassayMark Jesus M Magbanua, Michael Pugia, Jin Sun Lee, et al.
Blood|October 22, 2014
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
JCO Precision Oncology|March 28, 2025
Comprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated TumorCarolyn K McCourt, Jacob Gross, Kevin Kalinsky, et al.
Antiviral Research|May 12, 2006
Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 proteaseDavid A Davis, Cara A Brown, Kathleen E Singer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2010
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman diseaseThomas S Uldrick, Victoria Wang, Deirdre O'Mahony, et al.
Blood|November 1, 2013
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman diseaseMark N Polizzotto, Thomas S Uldrick, Victoria Wang, et al.
Blood|April 14, 2011
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapyThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Blood|September 12, 2007
Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcomaRichard F Little, Karen Aleman, Pallavi Kumar, et al.
Database : the Journal of Biological Databases and Curation|April 4, 2013
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptomeBenjamin Frederick Ganzfried, Markus Riester, Benjamin Haibe-Kains, et al.
Cancer Chemotherapy and Pharmacology|November 30, 2013
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancerTaofeek K Owonikoko, Joseph Aisner, Xin Victoria Wang, et al.
Plos One|October 27, 2015
A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex ImmunoassayMark Jesus M Magbanua, Michael Pugia, Jin Sun Lee, et al.
Blood|October 22, 2014
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
JCO Precision Oncology|March 28, 2025
Comprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated TumorCarolyn K McCourt, Jacob Gross, Kevin Kalinsky, et al.
Antiviral Research|May 12, 2006
Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 proteaseDavid A Davis, Cara A Brown, Kathleen E Singer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2010
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman diseaseThomas S Uldrick, Victoria Wang, Deirdre O'Mahony, et al.
Blood|November 1, 2013
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman diseaseMark N Polizzotto, Thomas S Uldrick, Victoria Wang, et al.
Blood|April 14, 2011
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapyThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
Pageof 13